Clinical Trial Update: Strategies for Management of Corneal Neovascularisation [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update on strategies for managing corneal neovascularisation, with no trial results or status details disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularisation

Snippet

Sponsor: University of Nottingham | Conditions: Corneal Neovascularisation | Phase 4 | Status: UNKNOWN